Ascoli Manufacturing Site: Oral Solids

The Pfizer CentreOne partner site in Ascoli, Italy, boasts a rich history of nearly five decades in high-quality oral solid dosage (OSD) manufacturing. Strategically situated in Central Italy, the facility supplies patients across the globe (over 100 countries) with vital medications.

This site prioritizes continuous advancement in scientific and manufacturing processes through strategic investments in resources, personnel, and collaborative partnerships. Our unwavering dedication to patient well-being is reflected in our long-standing contributions to global healthcare.

The Ascoli facility excels in delivering top-tier OSD medications while emphasizing flexibility, cost-effectiveness, speed, and paramount safety. Our expertise in complex, highly potent medications is underpinned by experience across over 40 OEB 1-5 product families. Additionally, we hold licenses for cytotoxic and controlled substance manufacturing.

Our commitment to quality and safety is unparalleled. A dedicated team of 150 quality professionals meticulously ensures adherence to rigorous standards. The on-site Quality Control laboratories conduct extensive analyses, solidifying the facility's pursuit of manufacturing excellence and unwavering product integrity.

By meticulously crafting every tablet and capsule, the Ascoli site empowers its partners to deliver groundbreaking treatments that have the potential to transform patients' lives.